Market revenue in 2023 | USD 477.2 million |
Market revenue in 2030 | USD 796.5 million |
Growth rate | 7.6% (CAGR from 2023 to 2030) |
Largest segment | Regular endotracheal |
Fastest growing segment | Reinforced Endotracheal Tube |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Regular Endotracheal, Reinforced Endotracheal Tube, Preformed Endotracheal Tube, Double-lumen Endotracheal Tube |
Key market players worldwide | Angiplast, Advin Health Care, Sterimed Group, ICU Medical Inc, Medtronic PLC, Teleflex Inc, ConvaTec Group PLC, Hollister, Medline Industries, BD, Pfm Medical |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to endotracheal tube market will help companies and investors design strategic landscapes.
Regular endotracheal was the largest segment with a revenue share of 32.12% in 2023. Horizon Databook has segmented the Asia Pacific endotracheal tube market based on regular endotracheal, reinforced endotracheal tube, preformed endotracheal tube, double-lumen endotracheal tube covering the revenue growth of each sub-segment from 2018 to 2030.
A large patient pool and the growing need for technologically improved and cost-effective healthcare solutions are predicted to create considerable regional growth potential in the market. As a result of low-cost services and increase in clinical trials, multinational businesses are making significant R&D investments to tap into untapped markets in Asia Pacific. These factors will have a significant impact on the market.
A few other factors promoting market expansion in the region are rise in hospital admissions and improvements in clinical development framework in developing nations. In addition, it is anticipated that in the coming years, the burden of chronic diseases and the growing older population in Asia Pacific would drive demand for endotracheal tube.
The three most prevalent diseases in the area, according to WHO, were cancer, diabetes, and cardiovascular disorders. However, the region's market expansion could be hampered by lack of advanced healthcare facilities, shortage of experienced professionals, and a poor reimbursement environment.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific endotracheal tube market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific endotracheal tube market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account